1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Laplante, S.R. Aubry, N. Bonneau, P.R. Cameron, D.R. Lagace, L. Massariol, M.-J. Montpetit, H. Ploufe, C. Kawai, S.H. Fulton, B.D. Chen, Z. Ni, F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C2 H4 O 44.053 ACETYL GROUP non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking N 1 N C N 2 N O N 3 N C N 4 N H N 5 N H N 6 N H N 7 N H N 8 N N N 9 S C N 10 N C N 11 N O N 12 N C N 13 N O N 14 N H N 15 N H N 16 N H N 17 N H N 18 N H N 19 N H N 20 N H N 21 N N N 22 S C N 23 N C N 24 N O N 25 N C N 26 N C N 27 N C N 28 N C N 29 N N N 30 N O N 31 N H N 32 N H N 33 N H N 34 N H N 35 N H N 36 N H N 37 N H N 38 N H N 39 N H N 40 N H N 41 N H N 42 N H N 43 N H N 44 N H N 45 N H N 46 N N N 47 S C N 48 N C N 49 N O N 50 N C N 51 N O N 52 N O N 53 N H N 54 N H N 55 N H N 56 N H N 57 N H N 58 N H N 59 N H N 60 N N N 61 S C N 62 N C N 63 N O N 64 N C Y 65 N C Y 66 N C Y 67 N C Y 68 N C Y 69 N C Y 70 N C N 71 N O N 72 N O N 73 N H N 74 N H N 75 N H N 76 N H N 77 N H N 78 N H N 79 N H N 80 N H N 81 N H N 82 N H N 83 N H N 84 N N N 85 S C N 86 N C N 87 N O N 88 N C N 89 N C N 90 N C N 91 N O N 92 N H N 93 N H N 94 N H N 95 N H N 96 N H N 97 N H N 98 N H N 99 N H N 100 N H N 101 N H N 102 N H N 1 N doub N 2 N sing N 3 N sing N 4 N sing N 5 N sing N 6 N sing N 7 N sing N 8 N sing N 9 N sing N 10 N sing N 11 N sing N 12 N sing N 13 N doub N 14 N sing N 15 N sing N 16 N sing N 17 N sing N 18 N sing N 19 N sing N 20 N sing N 21 N sing N 22 N sing N 23 N sing N 24 N sing N 25 N doub N 26 N sing N 27 N sing N 28 N sing N 29 N sing N 30 N sing N 31 N sing N 32 N sing N 33 N sing N 34 N sing N 35 N sing N 36 N sing N 37 N sing N 38 N sing N 39 N sing N 40 N sing N 41 N sing N 42 N sing N 43 N sing N 44 N sing N 45 N sing N 46 N sing N 47 N sing N 48 N sing N 49 N doub N 50 N sing N 51 N sing N 52 N sing N 53 N sing N 54 N sing N 55 N sing N 56 N sing N 57 N sing N 58 N sing N 59 N sing N 60 N sing N 61 N sing N 62 N doub N 63 N sing N 64 N sing N 65 N sing N 66 N sing Y 67 N doub Y 68 N sing Y 69 N sing N 70 N sing Y 71 N doub N 72 N sing Y 73 N doub N 74 N sing Y 75 N sing N 76 N sing N 77 N sing N 78 N sing N 79 N sing N 80 N sing N 81 N sing N 82 N sing N 83 N sing N 84 N sing N 85 N sing N 86 N doub N 87 N sing N 88 N sing N 89 N sing N 90 N sing N 91 N sing N 92 N sing N 93 N sing N 94 N sing N 95 N sing N 96 N sing N 97 N sing US Biochemistry BICHAW 0033 0006-2960 37 9793 9801 10.1021/bi980555v 9657693 Human cytomegalovirus protease complexes its substrate recognition sequences in an extended peptide conformation. 1998 10.2210/pdb1bfz/pdb pdb_00001bfz 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 593.693 HCMV PROTEASE R-SITE N-TERMINAL CLEAVAGE PRODUCT TERESYVKA N-TERMINAL RESIDUES OF R-SITE PEPTIDE 1 syn polymer no yes (ACE)SYVKA XSYVKA A polypeptide(L) n n n n n n chem_comp_atom chem_comp_bond database_2 pdbx_database_status pdbx_nmr_software struct_conn struct_site repository Initial release Version format compliance Atomic model Database references Derived calculations Non-polymer description Structure summary Version format compliance Data collection Database references Derived calculations Other 1 0 1999-05-25 1 1 2008-03-24 1 2 2011-07-13 1 3 2024-06-05 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _pdbx_nmr_software.name _struct_conn.pdbx_leaving_atom_flag _struct_conn.ptnr1_auth_comp_id _struct_conn.ptnr1_auth_seq_id _struct_conn.ptnr1_label_atom_id _struct_conn.ptnr1_label_comp_id _struct_conn.ptnr1_label_seq_id _struct_conn.ptnr2_auth_comp_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_atom_id _struct_conn.ptnr2_label_comp_id _struct_conn.ptnr2_label_seq_id _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id Y BNL 1998-05-25 REL TRANSFERRED NUCLEAR OVERHAUSER EFFECT SPECTROSCOPY 50, 150, 250 MS MIXING TIMES USED TO GENERATE RESTRAINTS POTENTIAL ENERGY, MINIMAL RESTRAINT VIOLATIONS 50 32 TRNOESY NOESY TOCSY 7.0 285 K REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE. CFF95 FORCEFIELD USED. RESTRAINED SIMULATED ANNEALING 4 0.5M NA2SO4, 50MM NACL, 1MM EDTA, 5MM DTT-D10 IN 10% D2O SPIKED WITH TSP-2,2,3,3-D4 MSI refinement Discover 95.5 structure solution Discover 95.5 400 Bruker AMX400 500 Bruker AMX500 600 Bruker DRX500 600 Bruker DMX600 ACE 6 n 1 ACE 6 A SER 5 n 2 SER 5 A TYR 4 n 3 TYR 4 A VAL 3 n 4 VAL 3 A LYS 2 n 5 LYS 2 A ALA 1 n 6 ALA 1 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 9.83 1.50 110.50 120.33 A A A N CA CB SER SER SER 5 5 5 N 3 9.88 1.50 110.50 120.38 A A A N CA CB SER SER SER 5 5 5 N 4 10.32 1.50 110.50 120.82 A A A N CA CB SER SER SER 5 5 5 N 5 9.77 1.50 110.50 120.27 A A A N CA CB SER SER SER 5 5 5 N 6 9.51 1.50 110.50 120.01 A A A N CA CB SER SER SER 5 5 5 N 8 9.48 1.50 110.50 119.98 A A A N CA CB SER SER SER 5 5 5 N 9 9.80 1.50 110.50 120.30 A A A N CA CB SER SER SER 5 5 5 N 10 11.42 1.50 110.50 121.92 A A A N CA CB SER SER SER 5 5 5 N 11 9.74 1.50 110.50 120.24 A A A N CA CB SER SER SER 5 5 5 N 12 11.13 1.50 110.50 121.63 A A A N CA CB SER SER SER 5 5 5 N 13 11.49 1.50 110.50 121.99 A A A N CA CB SER SER SER 5 5 5 N 14 11.30 1.50 110.50 121.80 A A A N CA CB SER SER SER 5 5 5 N 16 9.20 1.50 110.50 119.70 A A A N CA CB SER SER SER 5 5 5 N 18 9.74 1.50 110.50 120.24 A A A N CA CB SER SER SER 5 5 5 N 20 11.28 1.50 110.50 121.78 A A A N CA CB SER SER SER 5 5 5 N 21 11.51 1.50 110.50 122.01 A A A N CA CB SER SER SER 5 5 5 N 22 11.10 1.50 110.50 121.60 A A A N CA CB SER SER SER 5 5 5 N 23 9.73 1.50 110.50 120.23 A A A N CA CB SER SER SER 5 5 5 N 24 11.34 1.50 110.50 121.84 A A A N CA CB SER SER SER 5 5 5 N 25 9.71 1.50 110.50 120.21 A A A N CA CB SER SER SER 5 5 5 N 26 9.54 1.50 110.50 120.04 A A A N CA CB SER SER SER 5 5 5 N 28 11.38 1.50 110.50 121.88 A A A N CA CB SER SER SER 5 5 5 N 29 11.32 1.50 110.50 121.82 A A A N CA CB SER SER SER 5 5 5 N 30 9.66 1.50 110.50 120.16 A A A N CA CB SER SER SER 5 5 5 N 31 11.45 1.50 110.50 121.95 A A A N CA CB SER SER SER 5 5 5 N 32 10.29 1.50 110.50 120.79 A A A N CA CB SER SER SER 5 5 5 N 1 A A C OXT ALA ALA 1 1 0.126 0.019 1.229 1.355 N 2 A A C OXT ALA ALA 1 1 0.127 0.019 1.229 1.356 N 3 A A C OXT ALA ALA 1 1 0.126 0.019 1.229 1.355 N 4 A A C OXT ALA ALA 1 1 0.127 0.019 1.229 1.356 N 5 A A C OXT ALA ALA 1 1 0.126 0.019 1.229 1.355 N 6 A A C OXT ALA ALA 1 1 0.126 0.019 1.229 1.355 N 7 A A C OXT ALA ALA 1 1 0.131 0.019 1.229 1.360 N 8 A A C OXT ALA ALA 1 1 0.131 0.019 1.229 1.360 N 9 A A C OXT ALA ALA 1 1 0.131 0.019 1.229 1.360 N 10 A A C OXT ALA ALA 1 1 0.126 0.019 1.229 1.355 N 11 A A C OXT ALA ALA 1 1 0.127 0.019 1.229 1.356 N 12 A A C OXT ALA ALA 1 1 0.126 0.019 1.229 1.355 N 13 A A C OXT ALA ALA 1 1 0.131 0.019 1.229 1.360 N 14 A A C OXT ALA ALA 1 1 0.126 0.019 1.229 1.355 N 15 A A C OXT ALA ALA 1 1 0.130 0.019 1.229 1.359 N 16 A A C OXT ALA ALA 1 1 0.131 0.019 1.229 1.360 N 17 A A C OXT ALA ALA 1 1 0.132 0.019 1.229 1.361 N 18 A A C OXT ALA ALA 1 1 0.126 0.019 1.229 1.355 N 19 A A C OXT ALA ALA 1 1 0.131 0.019 1.229 1.360 N 20 A A C OXT ALA ALA 1 1 0.132 0.019 1.229 1.361 N 21 A A C OXT ALA ALA 1 1 0.126 0.019 1.229 1.355 N 22 A A C OXT ALA ALA 1 1 0.131 0.019 1.229 1.360 N 23 A A C OXT ALA ALA 1 1 0.135 0.019 1.229 1.364 N 24 A A C OXT ALA ALA 1 1 0.129 0.019 1.229 1.358 N 25 A A C OXT ALA ALA 1 1 0.126 0.019 1.229 1.355 N 26 A A C OXT ALA ALA 1 1 0.126 0.019 1.229 1.355 N 27 A A C OXT ALA ALA 1 1 0.131 0.019 1.229 1.360 N 28 A A C OXT ALA ALA 1 1 0.125 0.019 1.229 1.354 N 29 A A C OXT ALA ALA 1 1 0.131 0.019 1.229 1.360 N 30 A A C OXT ALA ALA 1 1 0.130 0.019 1.229 1.359 N 31 A A C OXT ALA ALA 1 1 0.126 0.019 1.229 1.355 N 32 A A C OXT ALA ALA 1 1 0.133 0.019 1.229 1.362 N 6 A LYS 2 -88.61 49.40 10 A LYS 2 -92.17 54.96 15 A TYR 4 75.20 177.66 BOUND CONFORMATION OF N-TERMINAL CLEAVAGE PRODUCT PEPTIDE MIMIC (P1-P9 OF RELEASE SITE) WHILE BOUND TO HCMV PROTEASE AS DETERMINED BY TRANSFERRED NOESY EXPERIMENTS (P1-P5 SHOWN ONLY), NMR, 32 STRUCTURES 1 Y N covale 1.376 both A SER 5 A N SER 2 1_555 A ACE 6 A C ACE 1 1_555 PEPTIDE SUBSTRIATE CLEAVAGE, BOUND CONFORMATION, EXTENDED CONFORMATION, substrate-based competitive inhibitor design 1BFZ PDB 1 1BFZ 6 1 1BFZ 6 1 1BFZ A 1 1 6 BINDING SITE FOR RESIDUE ACE A 6 A ACE 6 Software 2 A TYR 4 A TYR 3 2 1_555 A SER 5 A SER 2 2 1_555 1 P 1